Clinical trial · Interventional
Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients
NCT01885065CI-TRIAL-00010969completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Cancer of Head and Neck | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Dry Mouth | — | UNRESOLVED | — |
| Radiation-induced Xerostomia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gel-based artificial saliva | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Gel-based artificial saliva
- description
- Continuous oral intake of edible gel-based artificial saliva (30-50 ml/day) for four weeks
- interventionNames
- Other: Gel-based artificial saliva
Primary outcomes (1)
- measure
- Changes in subjective dry mouth score
- timeFrame
- baseline, 2 weeks and 4 weeks after intervention
- description
- The outcome measure (subjective dry mouth score) will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)
Secondary outcomes (3)
- measure
- Changes in objective dry mouth score
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * cancer patients who receive/ had received radiotherapy and/or chemotherapy and have dry mouth problems Exclusion Criteria: * mucositis more than grade 1 * cannot perform oral intake of gel-based artificial saliva eg. aspirate
References
Publications (0)
Data not yet available
No reference posted for this study.